Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Tracon Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +3 vs. Q2 2021
- Shares held
- 10.2M
- +1.34M (+15.1%) vs. Q2 2021
- Total value
- $39.6M
- −$18.1M (−31.4%) vs. Q2 2021
- New holders
- 9
- 11 more added
- Sold out
- 6
- 11 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 29 | $1.39M |
| Q4 2023 | 24 | $903.4K |
| Q3 2023 | 21 | $1.66M |
| Q2 2023 | 27 | $2.90M |
| Q1 2023 | 32 | $18.8M |
| Q4 2022 | 32 | $14.6M |
| Q3 2022 | 33 | $16.5M |
| Q2 2022 | 31 | $19.7M |
| Q1 2022 | 35 | $24.0M |
| Q4 2021 | 35 | $25.4M |
| Q3 2021 | 45 | $39.6M |
| Q2 2021 | 44 | $58.5M |
| Q1 2021 | 42 | $72.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 85 | $0 | 0.00% | −2,105−96.1% | Reduced |
| O'Shaughnessy Asset Management, LLC | 54 | $0 | 0.00% | −128−70.3% | Reduced |
| Deutsche Bank AG | 131 | $1.00K | 0.00% | −253,486−99.9% | Reduced |
| JPMorgan Chase & Co | 223 | $1.00K | 0.00% | −8,749−97.5% | Reduced |
| Truvestments Capital LLC | 318 | $1.00K | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 445 | $2.00K | 0.00% | +445 | New |
| Bank of America Corp | 739 | $3.00K | 0.00% | +599+427.9% | Added |
| Cutler Group LP | 1,200 | $4.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,330 | $5.00K | 0.00% | −7,429−84.8% | Reduced |
| Lindbrook Capital, LLC | 2,000 | $8.00K | 0.00% | −1,000−33.3% | Reduced |
| Goldman Sachs Group Inc | 10,755 | $42.0K | 0.00% | +10,755 | New |
| We Are One Seven, LLC | 11,780 | $44.0K | 0.01% | 00.0% | Unchanged |
| Hoylecohen, LLC | 13,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 14,072 | $53.0K | 0.00% | −19,413−58.0% | Reduced |
| CSS LLC | 14,900 | $58.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 14,938 | $58.0K | 0.01% | +14,938 | New |
| Northern Trust Corp | 17,337 | $67.0K | 0.00% | 00.0% | Unchanged |
| X-Square Capital, LLC | 17,973 | $70.0K | 0.04% | −3,000−14.3% | Reduced |
| Dimensional Fund Advisors LP | 22,595 | $87.0K | 0.00% | −34,740−60.6% | Reduced |
| Morgan Stanley | 24,704 | $96.0K | 0.00% | +13,177+114.3% | Added |
| ACT Capital Management, LLC | 28,500 | $110.0K | 0.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 36,466 | $141.0K | 0.00% | +23,204+175.0% | Added |
| Dowling & Yahnke LLC | 40,455 | $157.0K | 0.01% | 00.0% | Unchanged |
| Franklin Resources Inc | 43,700 | $169.0K | 0.00% | +43,700 | New |
| State Street Corp | 72,954 | $282.0K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 84,003 | $325.0K | 0.03% | +84,003 | New |
| Bank of New York Mellon Corp | 85,079 | $330.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 85,993 | $333.0K | 0.03% | +49,623+136.4% | Added |
| Telemetry Investments, L.L.C. | 130,500 | $505.0K | 0.69% | +90,500+226.3% | Added |
| Millennium Management LLC | 139,477 | $540.0K | 0.00% | +139,477 | New |
| Psagot Investment House Ltd. | 143,591 | $556.0K | 0.10% | +143,591 | New |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556.0K | 0.10% | +143,591 | New |
| Geode Capital Management, LLC | 145,745 | $564.0K | 0.00% | +7,923+5.7% | Added |
| Boothbay Fund Management, LLC | 268,301 | $1.04M | 0.04% | −25,730−8.8% | Reduced |
| Linden Advisors LP | 284,248 | $1.10M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 299,283 | $1.16M | 0.00% | +5,055+1.7% | Added |
| Renaissance Technologies LLC | 306,976 | $1.19M | 0.00% | +133,441+76.9% | Added |
| Two Sigma Investments, LP | 319,775 | $1.24M | 0.00% | +69,716+27.9% | Added |
| NEA Management Company, LLC | 346,718 | $1.34M | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 367,800 | $1.42M | 0.00% | +83,700+29.5% | Added |
| Vanguard Group Inc | 694,859 | $2.69M | 0.00% | +5,821+0.8% | Added |
| Altium Capital Management LP | 785,341 | $3.04M | 0.81% | +785,341 | New |
| Opaleye Management Inc. | 2,518,371 | $9.75M | 1.82% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 2,691,110 | $10.4M | 2.38% | −25,730−0.9% | Reduced |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −56,351−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −31,616−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −17,400−100.0% | Sold out |
| Vigilare Wealth Management | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Johnson & Johnson Innovation - JJDC, Inc. | – | – | – | – | Not filed |
| QS Investors, LLC | – | – | – | – | Not filed |